Pacer Advisors, Inc. Alector, Inc. Transaction History

Pacer Advisors, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$4.19 - $6.23 $3,000 - $4,460	-716 Reduced 55.59%	572 $2,000
Q1 2024 May 10, 2024	BUY	$5.69 - $8.08 $7,328 - $10,407	1,288 New	1,288 $7,000
Q2 2021 Jul 21, 2021	SELL	$15.5 - $22.48 $45,229 - $65,596	-2,918 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$14.84 - $22.23 $24,278 - $36,368	-1,636 Reduced 35.92%	2,918 $59,000
Q4 2020 Jan 20, 2021	BUY	$9.4 - $16.7 $25,624 - $45,524	2,726 Added 149.12%	4,554 $69,000
Q3 2020 Oct 19, 2020	BUY	$10.54 - $24.96 $19,267 - $45,626	1,828 New	1,828 $19,000

168

57.8M

146K

90.8K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.